Cullinan Therapeutics, Inc.
CGEM- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001789972
In the last 90 days, Cullinan Therapeutics, Inc. insiders filed 0 open-market purchases and 3 sales; 183 institutions reported holding it in 13F filings for Q2 2026, worth $1.30B in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Cullinan Therapeutics, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 144
- −4 vs. Q1 2025
- Shares held
- 62.6M
- −2.06M (−3.2%) vs. Q1 2025
- Total value
- $471.4M
- −$18.1M (−3.7%) vs. Q1 2025
- New holders
- 20
- 52 more added
- Sold out
- 24
- 44 more reduced
1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CGEM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 183 | $1.30B |
| Q1 2026 | 174 | $931.0M |
| Q4 2025 | 153 | $653.8M |
| Q3 2025 | 145 | $362.2M |
| Q2 2025 | 144 | $471.4M |
| Q1 2025 | 149 | $489.6M |
| Q4 2024 | 147 | $798.8M |
| Q3 2024 | 137 | $1.09B |
| Q2 2024 | 135 | $1.10B |
| Q1 2024 | 113 | $670.8M |
| Q4 2023 | 113 | $375.6M |
| Q3 2023 | 106 | $344.0M |
| Q2 2023 | 106 | $397.3M |
| Q1 2023 | 103 | $329.5M |
| Q4 2022 | 97 | $397.7M |
| Q3 2022 | 100 | $474.7M |
| Q2 2022 | 89 | $481.7M |
| Q1 2022 | 82 | $386.3M |
| Q4 2021 | 75 | $559.7M |
| Q3 2021 | 66 | $762.3M |
| Q2 2021 | 71 | $828.5M |
| Q1 2021 | 70 | $1.30B |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Cullinan Therapeutics, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BNP Paribas Arbitrage, SA | 129,344 | $974.0K | 0.00% | −377−0.3% | Reduced |
| Susquehanna International Group, LLP | 129,918 | $978.3K | 0.00% | +50,480+63.5% | Added |
| Verition Fund Management LLC | 139,660 | $1.05M | 0.01% | +110,485+378.7% | Added |
| Bank of New York Mellon Corp | 155,881 | $1.17M | 0.00% | +19,467+14.3% | Added |
| Caption Management, LLC | 175,427 | $1.32M | 0.12% | +175,427 | New |
| Nuveen, LLC | 180,685 | $1.36M | 0.00% | −7,345−3.9% | Reduced |
| Wellington Management Group LLP | 186,083 | $1.40M | 0.00% | +25,026+15.5% | Added |
| Algert Global LLC | 215,580 | $1.62M | 0.03% | −5,850−2.6% | Reduced |
| Morgan Stanley | 242,092 | $1.82M | 0.00% | −239,740−49.8% | Reduced |
| Voss Capital, LLC | 251,717 | $1.90M | 0.13% | +76,717+43.8% | Added |
| Affinity Asset Advisors, LLC | 263,817 | $1.99M | 0.29% | 00.0% | Unchanged |
| Barclays PLC | 268,467 | $2.02M | 0.00% | +27,124+11.2% | Added |
| UBS Group AG | 311,309 | $2.34M | 0.00% | +32,490+11.7% | Added |
| Renaissance Technologies LLC | 334,525 | $2.52M | 0.00% | −28,483−7.8% | Reduced |
| Charles Schwab Investment Management Inc | 435,516 | $3.28M | 0.00% | +11,254+2.7% | Added |
| Northern Trust Corp | 453,203 | $3.41M | 0.00% | −30,686−6.3% | Reduced |
| Millennium Management LLC | 510,828 | $3.85M | 0.00% | −272,349−34.8% | Reduced |
| Deutsche Bank AG | 566,781 | $4.27M | 0.00% | −8,750−1.5% | Reduced |
| Foresite Capital Management VI LLC | 594,025 | $4.47M | 2.51% | −40,533−6.4% | Reduced |
| Twin Focus Capital Partners, LLC | 595,489 | $4.48M | 0.63% | 00.0% | Unchanged |
| Marshall Wace, LLP | 626,581 | $4.72M | 0.01% | +58,582+10.3% | Added |
| Bank of America Corp | 661,285 | $4.98M | 0.00% | +136,900+26.1% | Added |
| Rock Springs Capital Management LP | 668,233 | $5.03M | 0.31% | +23,600+3.7% | Added |
| Goldman Sachs Group Inc | 702,138 | $5.29M | 0.00% | +53,181+8.2% | Added |
| Patient Square Capital LP | 868,897 | $6.54M | 2.36% | −10,000−1.1% | Reduced |
| Tang Capital Management LLC | 1,121,138 | $8.44M | 0.43% | 00.0% | Unchanged |
| Nextech Invest, Ltd. | 1,141,145 | $8.59M | 1.63% | 00.0% | Unchanged |
| Siren, L.L.C. | 1,193,410 | $8.99M | 0.47% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 1,276,538 | $9.61M | 0.00% | −26,683−2.0% | Reduced |
| Geode Capital Management, LLC | 1,279,496 | $9.64M | 0.00% | +37,679+3.0% | Added |
| VR Adviser, LLC | 1,379,965 | $10.4M | 0.78% | 00.0% | Unchanged |
| State Street Corp | 1,607,592 | $12.1M | 0.00% | −145,087−8.3% | Reduced |
| RTW Investments, LP | 1,705,960 | $12.8M | 0.18% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 1,923,855 | $14.5M | 0.36% | 00.0% | Unchanged |
| Kynam Capital Management, LP | 2,095,998 | $15.8M | 1.70% | −242,631−10.4% | Reduced |
| Franklin Resources Inc | 2,228,160 | $16.8M | 0.00% | +8,399+0.4% | Added |
| Blue Owl Capital Holdings LP | 2,385,972 | $18.0M | 5.80% | −50,000−2.1% | Reduced |
| Citadel Advisors LLC | 2,613,693 | $19.7M | 0.02% | −133,452−4.9% | Reduced |
| Vanguard Group Inc | 3,020,100 | $22.7M | 0.00% | −19,631−0.6% | Reduced |
| Deerfield Management Company, L.P. (Series C) | 3,855,552 | $29.0M | 0.53% | −5,287−0.1% | Reduced |
| BlackRock, Inc. | 4,217,933 | $31.8M | 0.00% | −2,929−0.1% | Reduced |
| Lynx1 Capital Management LP | 4,400,842 | $33.1M | 9.57% | +1,185,120+36.9% | Added |
| BVF Inc | 5,750,683 | $43.3M | 1.55% | 00.0% | Unchanged |
| MPM Oncology Impact Management LP | 7,648,268 | $57.6M | 9.98% | 00.0% | Unchanged |
| Braidwell LP | 0 | $0 | 0.00% | −980,773−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −81,741−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −81,721−100.0% | Sold out |
| Perceptive Advisors LLC | 0 | $0 | 0.00% | −80,100−100.0% | Sold out |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −32,903−100.0% | Sold out |
| Corebridge Financial, Inc. | 0 | $0 | 0.00% | −25,603−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −25,100−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −21,581−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −20,850−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −16,636−100.0% | Sold out |
| Oxford Asset Management LLP | 0 | $0 | 0.00% | −15,746−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −14,796−100.0% | Sold out |
| Axq Capital, LP | 0 | $0 | 0.00% | −14,255−100.0% | Sold out |
| Exchange Traded Concepts, LLC | 0 | $0 | 0.00% | −14,107−100.0% | Sold out |
| Profund Advisors LLC | 0 | $0 | 0.00% | −11,846−100.0% | Sold out |
| CIBC World Markets Corp | 0 | $0 | 0.00% | −11,597−100.0% | Sold out |
| Virginia Retirement Systems Et Al | 0 | $0 | 0.00% | −10,627−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −2,972−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −395−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −389−100.0% | Sold out |
| Coldstream Capital Management Inc | 0 | $0 | 0.00% | −207−100.0% | Sold out |
| Amundi | 0 | $0 | 0.00% | −40−100.0% | Sold out |
| Massmutual Trust Co FSB | 0 | $0 | 0.00% | −36−100.0% | Sold out |
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −29−100.0% | Sold out |
| Lindbrook Capital, LLC | – | – | – | – | Not filed |